Cleft lip with or without cleft palate is one of the most common birth defects of unknown etiology. A fraction of its genetic causes is attributable to copy number variations detected by array comparative genomic hybridization. The value of array comparative genomic hybridization screening as a first-tier test in the newborn population with multiple congenital anomalies has now been accepted. Due to unspecific clinical picture at this age, it can also be applied to neonates with isolated anomalies. Our purpose was to assess utility of array comparative genomic hybridization in the population of newborns with isolated cleft lip and palate. We conducted the study in a group of 52 Polish newborns with apparently isolated cleft lip and palate. In the study group, we found 8 rearrangements. Of these, 2 de novo events have been noted that potentially explain the phenotype. In addition, 2 novel candidate genes for cleft lip and palate, CHN2 and CDH19, are suggested. Given the high number of inherited potentially benign changes, we question the clinical utility of array comparative genomic hybridization in the newborn population with isolated cleft lip and palate, at the same time pointing to the need of skilled professional's clinical assessment at a later age. However, the value of this technology in searching for the cause of isolated anomalies cannot be underestimated.

1.
Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC: Cleft lip and palate. Lancet 2009;374:1773-1785.
2.
Murray JC: Gene/environment causes of cleft lip and/or palate. Clin Genet 2002;61:248-256.
3.
Vieira AR: Genetic and environmental factors in human cleft lip and palate; in Cobourne MT (ed): Cleft Lip and Palate: Epidemiology, Aetiology and Treatment. Front Oral Biol. Basel, Karger, 2012, vol 16, pp 19-31.
4.
Gorlin RJ, Cervenka J, Cohen MM: ‘Newer' facial clefting syndromes. Birth Defects Orig Artic Ser 1977;13:1-9.
5.
Kondo S, Schutte BC, Richardson RJ, et al: Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 2002;32:285-289.
6.
Stanier P, Moore GE: Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet 2004;13(spec No 1):R73-R81.
7.
Popp S, Schulze B, Granzow M, et al: Study of 30 patients with unexplained developmental delay and dysmorphic features or congenital abnormalities using conventional cytogenetics and multiplex FISH telomere (M-TEL) integrity assay. Hum Genet 2002;111:31-39.
8.
Vissers LE, de Vries BB, Osoegawa K, et al: Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003;73:1261-1270.
9.
Liu S, Joseph KS, Wen SW: Trends in fetal and infant deaths caused by congenital anomalies. Semin Perinatol 2002;26:268-276.
10.
Firth HV, et al: DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Am J Hum Genet 2009;84:524-533.
11.
Lu X-Y, Phung MT, Shaw CA, et al: Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics 2008;122:1310-1318.
12.
Slavotinek AM, Moshrefi A, Davis R, et al: Array comparative genomic hybridization in patients with congenital diaphragmatic hernia: mapping of four CDH-critical regions and sequencing of candidate genes at 15q26.1-15q26.2. Eur J Hum Genet 2006;14:999-1008.
13.
Greenway SC, Pereira AC, Lin JC, et al: De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009;41:931-935.
14.
Maarse W, Rozendaal AM, Pajkrt E, et al: A systematic review of associated structural and chromosomal defects in oral clefts: when is prenatal genetic analysis indicated? J Med Genet 2012;49:490-498.
15.
Nyberg DA, Sickler GK, Hegge FN, Kramer DJ, Kropp RJ: Fetal cleft lip with and without cleft palate: US classification and correlation with outcome. Radiology 1995;195:677-684.
16.
Maarse W, Pistorius LR, Van Eeten WK, et al: Prenatal ultrasound screening for orofacial clefts. Ultrasound Obstet Gynecol 2011;38:434-439.
17.
Rittler M, Cosentino V, Lopez-Camelo JS, et al: Associated anomalies among infants with oral clefts at birth and during a 1-year follow-up. Am J Med Genet A 2011;155A:1588-1596.
18.
Sang L, Miller JJ, Corbit KC, et al: Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. Cell 2011;145:513-528.
19.
Corbit KC, Aanstad P, Singla V, et al: Vertebrate Smoothened functions at the primary cilium. Nature 2005;437:1018-1021.
20.
Takeuchi S, Yamaki N, Iwasato T, Negishi M, Katoh H: Beta2-chimaerin binds to EphA receptors and regulates cell migration. FEBS Lett 2009;583:1237-1242.
21.
Gallego CJ, Grant J, Mikhail FM, Barger C, Robin NH: Use of array comparative genome hybridization in orofacial clefting. J Craniofac Surg 2010;21:1591-1594.
22.
Kohli SS, Kohli VS: A comprehensive review of genetic basis of cleft lip and palate. J Oral Maxillofac Pathol 2012;16:64-72.
23.
Vieira AR, Avila JR, Daack-Hirsch S, et al: Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet 2005;1:e64.
24.
Weiss LA, Shen Y, Korn JM, et al: Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-675.
25.
Benusiglio PR, Caron O, Consolino E, et al: Cleft lip, cleft palate, hereditary diffuse gastric cancer and germline mutations in CDH1. Int J Cancer 2013;132:2470.
26.
Seelan RS, Appana SN, Mukhopadhyay P, et al: Developmental profiles of the murine palatal methylome. Birth Defects Res A Clin Mol Teratol 2013;97:171-186.
27.
Zhou Z, Reed R: Human homologs of yeast Prp16 and Prp17 reveal conservation of the mechanism for catalytic step II of pre-mRNA splicing. EMBO J 1998;17:2095-2106.
28.
Jin T, Howard AJ, Golemis EA, et al: Overproduction, purification and crystallization and preliminary X-ray diffraction studies of the human spliceosomal protein TNXL4B. Acta Crystallogr Sect E Struct Biol Cryst Commun 2005;61:282-284.
29.
Ostapchenko VG, Gasparian ME, Kosinsky YA, et al: Dissecting structural basis of the unique substrate selectivity of human enteropeptidase catalytic subunit. J Biomol Struct Dyn 2012;30:62-73.
30.
Bause AS, Haigis MC: SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol 2013;48:634-639.
31.
Fernandez T, Morgan T, Davis N, et al: Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet 2004;74:1286-1293.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.